MuktaAroraMD

PubMed

• An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study.
  Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Oriol, Philippe Moreau, Ian McFadden, Qing Xia, Meletios Athanasios Dimopou...> ;Leukemia & Lymphoma. 2024 Mar 18
• 1 citations
  Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.
  Catherine J Lee, Tao Wang, Karen Chen, Mukta Arora, Ruta Brazauskas, Stephen R Spellman, Carrie Kitko, Margaret L MacMillan, Joseph A Pidala, Sherif M Badawy, Neel Bha...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• Frailty in Patients with Chronic Graft-versus-Host Disease.
  Nahid Rashid, Mukta Arora, Najla El Jurdi, Lynn Onstad, Joseph A Pidala, Mary E Flowers, Stephanie J Lee> ;Transplantation and Cellular Therapy. 2023 Jun 1
• 1 citations
  Neighborhood disadvantage, health status, and health care utilization after blood or marrow transplant: BMTSS report.
  Wolfson, J., Bhatia, S., Hageman, L., Ross, E., Balas, N., Bosworth, A., Te, H., Francisco, L., Funk, E., Hicks, J., Landier, W., Wu, J., Siler, A., Lim, S., Wong, F.,...> ;Blood Advances. 2023 Feb 14
• 1 citations
  Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS Report.
  Bhatia, S., Dai, C., Hageman, L., Wu, J., Schlichting, E., Siler, A., Funk, E., Hicks, J., Lim, S., Balas, N., Bosworth, A., Te, H., Francisco, L., Bhatia, R., Forman,...> ;Journal of Clinical Oncology. 2023 Feb 10
• 9 citations
  Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.
  Carrie L Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi, Vedran Radojcic, Courtney B Betts, Lisa M Coussens, Michael L Meyers, Hope Qamoos...> ;Journal of Clinical Oncology. 2023 Apr 1
• 1 citations
  Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182].
  Anita D'Souza, Caitrin Fretham, Stephanie J Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra, Steven Devine, Mary Eapen, Mehdi Hamadani, Parameswaran Hari, Marcelo C P...> ;Transplantation and Cellular Therapy. 2022 Oct 1
• 2 citations
  Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
  Catherine J Lee, Tao Wang, Karen Chen, Mukta Arora, Ruta Brazauskas, Stephen R Spellman, Carrie Kitko, Margaret L MacMillan, Joseph A Pidala, Jeffery J Auletta, Sherif...> ;Transplantation and Cellular Therapy. 2022 Oct 1
• 11 citations
  Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
  Rima M Saliba, Amin M Alousi, Joseph Pidala, Mukta Arora, Stephen R Spellman, Michael T Hemmer, Tao Wang, Camille Abboud, Sairah Ahmed, Joseph H Antin, Amer Beitinjane...> ;Transplantation and Cellular Therapy. 2022 Oct 1
• 5 citations
  Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
  Saro H Armenian, Yanjun Chen, Lindsay Hageman, Jessica Wu, Wendy Landier, Alysia Bosworth, Liton Francisco, Elizabeth Schlichting, Ravi Bhatia, Donna Salzman, F Lennie...> ;Journal of Clinical Oncology. 2022 Oct 1
• 8 citations
  Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report.
  Bhatia, S., Dai, C., Landier, W., Hageman, L., Wu, J., Schlichting, E., Siler, A., Funk, E., Hicks, J., Lim, S., Balas, N., Bosworth, A., Te, H., Francisco, L., Bhatia...> ;Journal of Clinical Oncology. 2022 Jun 20
• 2 citations
  Durable discontinuation of systemic therapy in patients affected by chronic graft--host disease.
  George L Chen, Lynn Onstad, Paul J Martin, Paul Carpenter, Joseph Pidala, Sally Arai, Corey Cutler, Betty K Hamilton, Stephanie J Lee, Mukta Arora> ;Haematologica. 2023 Feb 1
• 2 citations
  Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease fo...
  Jo-Anne H Young, Najla El Jurdi, Ahmad Rayes, Margaret L MacMillan, Shernan G Holtan, Qing Cao, Judith Witte, Mukta Arora, Daniel J Weisdorf> ;Transplantation and Cellular Therapy. 2022 Aug 1
• 3 citations
  Predictors and outcomes of flares in chronic graft-versus-host disease.
  Najla El Jurdi, Grigori Okoev, Todd E DeFor, Shernan G Holtan, Brian C Betts, Bruce R Blazar, Claudio G Brunstein, Margaret L MacMillan, Daniel J Weisdorf, Mukta Arora> ;Bone Marrow Transplantation. 2022 May 1
• 3 citations
  Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report.
  Nora Balas, Lindsey Hageman, Jessica Wu, Liton Francisco, Elizabeth Schlichting, Alysia Bosworth, Hok Sreng Te, F Lennie Wong, Wendy Landier, Donna Salzman, Daniel J W...> ;Blood Advances. 2022 Apr 26
• Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients.
  Divya Bhargava, Cathleen Drilling, Todd E DeFor, Claudio G Brunstein, Bharat Thyagarajan, Najla El Jurdi, Shernan G Holtan, Armin Rashidi, Erica Warlick, Vidhyalakshmi...> ;Bone Marrow Transplantation. 2022 Jul 1
• 22 citations
  Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.
  Rachel Phelan, Min Chen, Caitrin Bupp, Yung-Tsi Bolon, Larisa Broglie, Janet Brunner-Grady, Linda J Burns, Saurabh Chhabra, Debra Christianson, Rachel Cusatis, Steven ...> ;Transplantation and Cellular Therapy. 2022 Jul 1
• Burden of Morbidity after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor Study Report.
  Wadhwa, A., Chen, Y., Hageman, L., Schlichting, E., Funk, E., Hicks, J., Balas, N., Siler, A., Wu, J., Francisco, L., Holmqvist, A., Gupta, A., Lund, T., Orchard, P., ...> ;Transplantation and Cellular Therapy. 2022 Mar 1
• 10 citations
  Association of CD34 cell dose with 5-year overall survival after peripheral blood allogeneic hematopoietic cell transplantation in adults with hematologic malignancies.
  Timothy D. Gauntner, Claudio G. Brunstein, Qing Cao, Daniel J. Weisdorf, Erica D. Warlick, Najla El Jurdi, Joseph Maakaron, Mukta Arora, Brian C. Betts, Veronika Bacha...> ;Transplantation and Cellular Therapy. 2021 Nov 10
• 3 citations
  Phase 2 multicenter trial of ofatumumab and prednisone as initial therapy of chronic graft-vs-host disease
  Aleksandr Lazaryan, Stephanie J. Lee, Mukta Arora, Jongphil Kim, Brian C. Betts, Farhad Khimani, Taiga Nishihori, Nelli Bejanyan, Hien Liu, Mohamed A. Kharfan-Dabaja, ...> ;Blood Advances. 2021 Oct 14
• 11 citations
  Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoieti...
  Vijaya Raj Bhatt, Tao Wang, Karen Chen, Carrie L. Kitko, Margaret L. MacMillan, Joseph A. Pidala, Monzr M. Al Malki, Sherif M. Badawy, Amer Beitinjaneh, Siddhartha Gan...> ;Transplantation and Cellular Therapy. 2021 Oct 9
• 1 citations
  Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation-A Blood or Marrow Transplant Surviv...
  Smith Giri, Yanjun Chen, Jessica Wu, Lindsey Hageman, Joshua S. Richman, Liton Francisco, Wendy Landier, Luciano J. Costa, Andrew M. McDonald, Donna L. Murdaugh, F. Le...> ;Transplantation and Cellular Therapy. 2021 Oct 1
• 8 citations
  Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival.
  Joseph Pidala, Lynn Onstad, Paul J. Martin, Betty K. Hamilton, Corey Cutler, Carrie L. Kitko, Paul A. Carpenter, George Chen, Mukta Arora, M.E. Flowers, Sally Arai, Am...> ;Blood Advances. 2021 Nov 23
• 34 citations
  Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
  Zachariah DeFilipp, Amin M. Alousi, Joseph Pidala, Paul A. Carpenter, Lynn Onstad, Sally Arai, Mukta Arora, Corey Cutler, Mary E.D. Flowers, Carrie L. Kitko, George Ch...> ;Blood Advances. 2021 Oct 26
• 9 citations
  Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model
  Radhika Gangaraju, Yanjun Chen, Lindsey Hageman, Jessica Wu, Liton Francisco, Michelle Kung, Daniel J. Weisdorf, Stephen J. Forman, Mukta Arora, Saro H. Armenian> ;Blood Advances. 2021 Oct 26
• Join now to see all

Journal Articles

• Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source, Conditioning Regiment Toxicity, and Engraftment Kinetics  
  Erhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel J Weisdorf, Nelli Bejanyan, Claudio G Brunstein, Celalettin Ustun, Aleksandr Lazaryan, Ver..., Haematologica
• A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...  
  Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica
• Late Mortality After Allogeneic Blood or Marrow Transplantation in Childhood for Leukemia: A Report from the Blood or Marrow Transplant Survivor Study-2  
  Stephen J Forman, Daniel J Weisdorf, Donna Salzman, Mukta Arora, Saro H Armenian, Nature

Abstracts/Posters

• Burden of Long-Term Morbidity Borne By Survivors of Acute Myeloid Leukemia (AML) Treated with Blood or Marrow Transplantation (BMT) _ a Report from the BMT Survivor St...
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Stroke Risk in Blood or Marrow Transplant (BMT) Survivors _ a Report from the BMT Survivor Study (BMTSS)
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantatio...
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) - Results of the BMT Survivor Study (BMTSS) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018